Your browser doesn't support javascript.
loading
Efficacy and safety of COVID-19 vaccines.
Graña, Carolina; Ghosn, Lina; Evrenoglou, Theodoros; Jarde, Alexander; Minozzi, Silvia; Bergman, Hanna; Buckley, Brian S; Probyn, Katrin; Villanueva, Gemma; Henschke, Nicholas; Bonnet, Hillary; Assi, Rouba; Menon, Sonia; Marti, Melanie; Devane, Declan; Mallon, Patrick; Lelievre, Jean-Daniel; Askie, Lisa M; Kredo, Tamara; Ferrand, Gabriel; Davidson, Mauricia; Riveros, Carolina; Tovey, David; Meerpohl, Joerg J; Grasselli, Giacomo; Rada, Gabriel; Hróbjartsson, Asbjørn; Ravaud, Philippe; Chaimani, Anna; Boutron, Isabelle.
  • Graña C; Cochrane France, Paris, France.
  • Ghosn L; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Evrenoglou T; Cochrane France, Paris, France.
  • Jarde A; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Minozzi S; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Bergman H; Cochrane France, Paris, France.
  • Buckley BS; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Probyn K; Cochrane Review Group on Drugs and Alcohol, Rome, Italy.
  • Villanueva G; Cochrane Response, Cochrane, London, UK.
  • Henschke N; Cochrane Response, Cochrane, London, UK.
  • Bonnet H; Cochrane Response, Cochrane, London, UK.
  • Assi R; Cochrane Response, Cochrane, London, UK.
  • Menon S; Cochrane Response, Cochrane, London, UK.
  • Marti M; Cochrane France, Paris, France.
  • Devane D; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Mallon P; Cochrane France, Paris, France.
  • Lelievre JD; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Askie LM; Cochrane France, Paris, France.
  • Kredo T; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Ferrand G; Evidence Synthesis Ireland, Cochrane Ireland and HRB-Trials Methodology Research Network, National University of Ireland, Galway, Ireland.
  • Davidson M; UCD Centre for Experimental Pathogen Host Research and UCD School of Medicine, University College Dublin, Dublin, Ireland.
  • Riveros C; Department of Clinical Immunology and Infectious Diseases, Henri Mondor Hospital, Vaccine Research Institute, Université Paris Est Créteil, Paris, France.
  • Tovey D; Quality Assurance Norms and Standards Department, World Health Organization, Geneva, Switzerland.
  • Meerpohl JJ; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
  • Grasselli G; Cochrane France, Paris, France.
  • Rada G; Cochrane France, Paris, France.
  • Hróbjartsson A; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Ravaud P; Cochrane France, Paris, France.
  • Chaimani A; Centre of Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, Paris, France.
  • Boutron I; Cochrane France, Paris, France.
Cochrane Database Syst Rev ; 12: CD015477, 2022 12 07.
Article en En | MEDLINE | ID: mdl-36473651
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna nCoV-2019 mRNA-1273 Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Adolescent / Aged / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna nCoV-2019 mRNA-1273 Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Adolescent / Aged / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article